Daewoong pharmaceutical

069620.KO

90.27 USD

0.36

+0.40%

Overview

Last close

90.27 usd

Market cap

1.04B usd

52 week high

119.39 usd

52 week low

72.15 usd

Target price

141.6 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0595

Price/Book Value

1.8708

Enterprise Value

1.40B usd

EV/Revenue

1.4195

EV/EBITDA

17.9488

Key financials

Revenue TTM

985.67M usd

Gross Profit TTM

507.99M usd

EBITDA TTM

134.56M usd

Earnings per Share

N/A usd

Dividend

0.42 usd

Total assets

1.34B usd

Net debt

368.41M usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.